Novavax Inc. Stock Rises 8.0%, Outperforms Peers
Dow Jones2026/09/01 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. rose 8.0% to $10.12 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.
This was the stock's third consecutive day of gains.
Novavax Inc. closed 15.5% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Merck & Co. Inc. rose 1.42% to $149.86.
Trading volume totaled 10.0 million, compared to the 50-day average of 4.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 01, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The proportion of Bitcoin holders at a loss is declining
Euro remains stronger against Canadian Dollar following Eurozone HICP inflation data
Innovative Drug Export: Why Is This Window Two Weeks Later So Important?
Why did India suddenly make massive purchases of US Treasuries? July net purchase hit a record $15.2 billion, with a special swap mechanism as the key factor
Benefiting from a special arrangement by the Reserve Bank of India to attract overseas capital, India purchased a record amount of US Treasury bonds in July due to large capital inflows.
Crypto prices
More
